Literature DB >> 11906322

Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentrations in humans.

S M Freudenthaler1, K-H Schreeb, A Wiese, J Pilz, C H Gleiter.   

Abstract

UNLABELLED: The present study was carried out to evaluate a model of a hypoxic stimulus of erythropoietin (EPO) production in humans and to investigate the role of free oxygen radicals in human EPO production. The study was conducted as an open, randomized, parallel, placebo-controlled trial. Thirty-six healthy male volunteers received a hypoxic treatment (13% O(2)) with a respiration mask for 6 h. During the period of hypoxia, the volunteers received as a short-term treatment either 1200 mg thioctic acid, or N-acetylcysteine 600 mg or placebo (0.9% sodium chloride). The EPO concentration in plasma increased up to 290% of the baseline level in all three groups. No statistically significant differences of AUC(EPO(0-48 h)) could be demonstrated between the groups. The malondialdehyde (MDA) concentration in plasma increased significantly (P < 0.001) 2 h after termination of hypoxia (mean 129.8 +/- 6.8% of the baseline) in all three groups.
CONCLUSIONS: Taken together, our in-vivo results do not support a gross modulatory effect of a short-term treatment with radical scavenging agents on EPO-production during or after hypoxia in humans, as derived from the detected changes of MDA-concentrations in peripheral plasma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906322     DOI: 10.1046/j.1365-201x.2002.00946.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  9 in total

1.  Modulatory effect of N-acetylcysteine on pro-antioxidant status and haematological response in healthy men.

Authors:  A Zembron-Lacny; M Slowinska-Lisowska; Z Szygula; Z Witkowski; K Szyszka
Journal:  J Physiol Biochem       Date:  2010-03-31       Impact factor: 4.158

2.  Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.

Authors:  W Jordan; S Cohrs; D Degner; A Meier; A Rodenbeck; G Mayer; J Pilz; E Rüther; J Kornhuber; S Bleich
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

3.  Effect of N-acetyl-cysteine and hyperoxia on erythropoietin production.

Authors:  Mona Momeni; Marc De Kock; Olivier Devuyst; Giuseppe Liistro
Journal:  Eur J Appl Physiol       Date:  2011-03-11       Impact factor: 3.078

4.  Effects of Wy14643 on hepatic ischemia reperfusion injury in rats.

Authors:  Si-Qi Xu; Yuan-Hai Li; Sheng-Hong Hu; Ke Chen; Liu-Yi Dong
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

5.  Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?

Authors:  S Freudenthaler; P Benöhr; A Grenz; T Selzer; T Schmidt; K Mörike; H Osswald; C H Gleiter
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

6.  Interaction of L-arginine-methyl ester and Sonic hedgehog in liver ischemia-reperfusion injury in the rats.

Authors:  Mehmet-Cudi Tuncer; Hayrettin Ozturk; Huseyin Buyukbayram; Hulya Ozturk
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

7.  Protective Effects of Peroxisome Proliferator-Activated Receptor-α Agonist, Wy14643, on Hypoxia/Reoxygenation Injury in Primary Rat Hepatocytes.

Authors:  Ke Chen; Yuan-Hai Li; Si-Qi Xu; Sheng-Hong Hu; Lei Zhang
Journal:  PPAR Res       Date:  2011-10-09       Impact factor: 4.964

Review 8.  Nutrition and Altitude: Strategies to Enhance Adaptation, Improve Performance and Maintain Health: A Narrative Review.

Authors:  Trent Stellingwerff; Peter Peeling; Laura A Garvican-Lewis; Rebecca Hall; Anu E Koivisto; Ida A Heikura; Louise M Burke
Journal:  Sports Med       Date:  2019-12       Impact factor: 11.136

9.  THE COMBINATION OF α-LIPOIC ACID INTAKE WITH ECCENTRIC EXERCISE MODULATES ERYTHROPOIETIN RELEASE.

Authors:  B Morawin; D Turowski; M Naczk; I Siatkowski; A Zembron-Lacny
Journal:  Biol Sport       Date:  2014-07-15       Impact factor: 2.806

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.